PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing 101111, China.\', \'AnyGo Technology Co., LTD, D1117 Xinhua International Plaza, 89 Dayangfan Rd, Beijing, China.\', \'Institute of Microbiology Chinese Academy of Sciences, China.\', \'ZhenGe Biotechnology Co., LTD, Shanghai, China.\', \'SinoVac, Beijing, China.\', \'Advaccine (Suzhou) Biopharmaceuticals, Co., LTD, Suzhou, Jiangsu, China.\', \'Dept. Lab Medine, Nanjing Univ. Medical School, Nanjing, Jiangsu 210008, China.\', \'College of Public Health, Fudan Univ., Shanghai, China.\', \'AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing 101111, China. Electronic address: limh@antibodychina.com.\', \'AnyGo Technology Co., LTD, D1117 Xinhua International Plaza, 89 Dayangfan Rd, Beijing, China; AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing 101111, China. Electronic address: sunl@antibodychina.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(20)30852-510.1016/j.vaccine.2020.06.066
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 32651113
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32651113>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32651113>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all